These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8430432

  • 21. Human platelet acetylcholinesterase inhibition by cyclophosphamide: a combined experimental and computational approach.
    Al-Jafari AA, Shakil S, Reale M, Kamal MA.
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):928-35. PubMed ID: 22229321
    [Abstract] [Full Text] [Related]

  • 22. Multiple approaches to analyse the data for rat brain acetylcholinesterase inhibition by cyclophosphamide.
    Kamal MA, Reale M, Al-Jafari AA.
    Neurochem Res; 2010 Oct; 35(10):1501-9. PubMed ID: 20652634
    [Abstract] [Full Text] [Related]

  • 23. Effect of malathion on kinetic parameters of acetylcholinesterase (EC 3.1.1.7) in vitro.
    Kamal MA.
    Biochem Mol Biol Int; 1997 Sep; 43(1):89-97. PubMed ID: 9315286
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity of bovine retinal acetylcholinesterase (E.C. 3.1.1.7) toward tacrine: kinetic characterization.
    al-Jafari AA, Kamal MA, Alhomida AS.
    J Biochem Mol Toxicol; 1998 Sep; 12(4):245-51. PubMed ID: 9580877
    [Abstract] [Full Text] [Related]

  • 25. Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases.
    Khalid A, Zaheer-ul-Haq, Anjum S, Khan MR, Atta-ur-Rahman, Choudhary MI.
    Bioorg Med Chem; 2004 May 01; 12(9):1995-2003. PubMed ID: 15080903
    [Abstract] [Full Text] [Related]

  • 26. In vitro inhibitory effect of aflatoxin B1 on acetylcholinesterase activity in mouse brain.
    Cometa MF, Lorenzini P, Fortuna S, Volpe MT, Meneguz A, Palmery M.
    Toxicology; 2005 Jan 05; 206(1):125-35. PubMed ID: 15590113
    [Abstract] [Full Text] [Related]

  • 27. Lignocaine: inhibitory effect on synaptosomal and erythrocyte membrane-bound acetylcholinesterase activity.
    Haque SJ, Poddar MK.
    Biochem Pharmacol; 1983 Nov 15; 32(22):3443-6. PubMed ID: 6651866
    [Abstract] [Full Text] [Related]

  • 28. Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine.
    Kamal MA, Greig NH, Alhomida AS, Al-Jafari AA.
    Biochem Pharmacol; 2000 Aug 15; 60(4):561-70. PubMed ID: 10874131
    [Abstract] [Full Text] [Related]

  • 29. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
    Milatovic D, Dettbarn WD.
    Toxicol Appl Pharmacol; 1996 Jan 15; 136(1):20-8. PubMed ID: 8560475
    [Abstract] [Full Text] [Related]

  • 30. Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase.
    Kamal MA.
    Anticancer Res; 1996 Jan 15; 16(6B):3725-30. PubMed ID: 9042248
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vivo inhibition of chicken brain acetylcholinesterase and neurotoxic esterase in relation to the delayed neurotoxicity of leptophos and cyanofenphos.
    Soliman SA, Curley A, Farmer J, Novak R.
    J Environ Pathol Toxicol Oncol; 1986 Jan 15; 7(1-2):211-24. PubMed ID: 2432215
    [Abstract] [Full Text] [Related]

  • 33. Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy.
    Choudhary MI, Nawaz SA, Zaheer-ul-Haq, Azim MK, Ghayur MN, Lodhi MA, Jalil S, Khalid A, Ahmed A, Rode BM, Atta-ur-Rahman, Gilani AU, Ahmad VU.
    Biochem Biophys Res Commun; 2005 Jul 15; 332(4):1171-7. PubMed ID: 16021692
    [Abstract] [Full Text] [Related]

  • 34. Isolation and cholinesterase-inhibition studies of sterols from Haloxylon recurvum.
    Ahmed E, Nawaz SA, Malik A, Choudhary MI.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(3):573-80. PubMed ID: 16274989
    [Abstract] [Full Text] [Related]

  • 35. Comparative sensitivity of bovine and rodent acetylcholinesterase to in vitro inhibition by organophosphate insecticides.
    Cohen SD, Williams RA, Killinger JM, Freudenthal RI.
    Toxicol Appl Pharmacol; 1985 Dec 15; 81(3 Pt 1):452-9. PubMed ID: 2417385
    [Abstract] [Full Text] [Related]

  • 36. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
    Chemnitius JM, Haselmeyer KH, Gonska BD, Kreuzer H, Zech R.
    Pharmacol Res; 1996 Dec 15; 34(1-2):65-72. PubMed ID: 8981558
    [Abstract] [Full Text] [Related]

  • 37. Kinetic analysis of inhibition of brain and red blood cell acetylcholinesterase and plasma cholinesterase by acephate or methamidophos.
    Singh AK.
    Toxicol Appl Pharmacol; 1985 Nov 15; 81(2):302-9. PubMed ID: 4060156
    [Abstract] [Full Text] [Related]

  • 38. 2,5-Hexanedione inhibits rat brain acetylcholinesterase activity in vitro.
    Pereira ME, Adams AI, Silva NS.
    Toxicol Lett; 2004 Feb 02; 146(3):269-74. PubMed ID: 14687764
    [Abstract] [Full Text] [Related]

  • 39. Molecular determinants of the species-selective inhibition of brain acetylcholinesterase.
    Kemp JR, Wallace KB.
    Toxicol Appl Pharmacol; 1990 Jun 15; 104(2):246-58. PubMed ID: 2363176
    [Abstract] [Full Text] [Related]

  • 40. Dual temperature model for the estimation of energetics parameters for acetylcholinesterase inhibition by cyclophosphamide.
    Kamal MA.
    Biochem Mol Biol Int; 1997 Oct 15; 43(3):571-81. PubMed ID: 9352076
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.